HKU Scholars Hub: Browsing DSpace

Browsing by Author Brunetto, MR

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 2 to 7 of 7 < previous

	Title	Author(s)	Issue Date	Views
	Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study Journal:The Lancet Gastroenterology & Hepatology	Blach, S Terrault NA Tacke, F Gamkrelidze, I Craxi, A Tanaka, J Waked, I Dore, GJ Abbas, Z Abdallah, AR Abdulla, M Aghemo, A Aho, I Akarca, US Alalwan, AM Blome, MA Al-Busafi, SA Aleman, S Alghamdi, AS Al-Hamoudi, WK Aljumah, AA Al-Naamani, K Al Serkal, YM Altraif, IH Anand, AC Anderson, M Andersson, MI Athanasakis, K Baatarkhuu, O Bakieva, SR Ben-Ari, Z Bessone, F Biondi, MJ Bizri, ARN Mello, CEB Brigida, K Brown, KA Brown, RS Bruggmann, P Brunetto, MR Busschots, D Buti, M Butsashvili, M Cabezas, J Chae, C Ivanova, VC Chan, HLY Cheinquer, H Cheng, KJ Cheon, ME Chien, CH Chien, RN Choudhuri, G Christensen, PB Chuang, WL Chulanov, V Cisneros, LE Coco, B Contreras, FA Cornber,g M Cramp, ME Crespo, J Cui, F Cunningham, CW Abou, LD Dalgard, O Dao, DY Yuen, MF	6-Apr-2022
	IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) Proceeding/Conference:Hepatology	Lim, Y Chan, HLY Seto, WKW Ning, Q Agarwal, K Janssen, HL Pan, CQ Chuang, WL Izumi, N Fung, SK Shalimar,Brunetto, MR Flaherty, JF Mo, S Cheng, C Lin, L Gaggar, A Subramanian, M Marcellin, P Gane, EJ Hou, J Buti, M	2019	120
	Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B	Bonino, F Marcellin, P Lau, GKK Hadziyannis, S Jin, R Piratvisuth, T Germanidis, G Yurdaydin, C Diago, M Gurel, S Lai, MY Brunetto, MR Farci, P Popescu, M McCloud, P	2007	175
	RETRACTION: Improved Bone Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate Over 2 Years in Patients With Chronic HBV Infection Journal:Clinical Gastroenterology and Hepatology	Seto, WKW Asahina, Y Brown, TT Peng, CY Stanciu, C Abdurakhmanov, D Tabak, F Nguyen, TT Chuang, WL Inokuma, T Ikeda, F Santantonio, TA Habersetzer, F Ramji, A Lau, AH Suri, V Flaherty, JF Wang, H Gaggar, A Subramanian, GM Mukewar, S Brunetto, MR Fung, S Chan, HL	2018	50
	Three Year Efficacy and Safety of Tenofovir Alafenamide (TAF) Compared to Tenofovir Disoproxil Fumarate (TDF) in Hbeag-Negative and Hbeag-Positive Patients with Chronic Hepatitis B Proceeding/Conference:Hepatology	Chan, HLY Lim, YS Seto, WKW Agarwal, K Brunetto, MR Janssen, HLA Caruntu, F Stepanova, T Tsang, O Yatsuhashi, H Tak, WY Chen, CY Celen, M Sun, V Flaherty, JF Lin, L Cathcart, A Gaggar, A Pan, CQ Shalimar Buti, M	2018	384
	Update of the statements on biology and clinical impact of occult hepatitis B virus infection Journal:Journal of Hepatology	Raimondo, G Locarnini, S Pollicino, T Levrero, M Zoulim, F Lok, AS Allain, JP Berg, T Bertoletti, A Brunetto, MR Bruno, R Chen, DS Coppola, N Cornberg, M Craxì, A Dandri, M Di Marco, V Ferrari, C Gaeta, GB Glebe, D Guidotti, LG Kramvis, A Lampertico, P Li, C Liang, J Marzano, A Michalak, TI Pawlotsky, JM Prati, D Puoti, M Samuel, D Soriano, V Squadrito, G Sureau, C Trepo, C Yuen, MF	2019	51

Showing results 2 to 7 of 7 < previous